Open AccessEstimated Population-Level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United States
Author(s) -
Sourya Shrestha,
Andrea Parriott,
Nicolas A. Menzies,
Priya B. Shete,
Andrew Hill,
Suzanne M. Marks,
David W. Dowdy
Publication year - 2020
Publication title -
annals of the american thoracic society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 114
eISSN - 2329-6933
pISSN - 2325-6621
DOI - 10.1513/annalsats.202005-574rl
Subject(s) - rifapentine , medicine , regimen , latent tuberculosis , tuberculosis , population , mycobacterium tuberculosis , environmental health , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom